Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SUDARONE THIHALOLIPAVAN

Allopathic & Osteopathic Physicians Internal Medicine Clinical Cardiac Electrophysiology

NPI
1528220050
CMS profile
776800
Location
LITTLE ROCK, AR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$15,408.48

175 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 4; records 51–100 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SUDARONE THIHALOLIPAVAN

NPI 1528220050 · CMS profile ID 776800

Allopathic & Osteopathic Physicians / Internal Medicine / Clinical Cardiac Electrophysiology

LITTLE ROCK, AR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1528220050?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SUDARONE THIHALOLIPAVAN, NPI 1528220050, CMS profile ID 776800. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1528220050?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). SUDARONE THIHALOLIPAVAN, NPI 1528220050, CMS profile ID 776800. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1528220050?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
SUDARONE THIHALOLIPAVAN, NPI 1528220050, CMS profile ID 776800, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1528220050?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

175 matching records · $15,408.48 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 175 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 175.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Impulse Dynamics (USA) Inc. $9.6109/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947561217 CMS
Novartis Pharmaceuticals Corporation $18.5109/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894416653 CMS
Impulse Dynamics (USA) Inc. $134.0309/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559695 CMS
Biosense Webster, Inc. $30.3409/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015027 CMS
Abbott Laboratories $17.6609/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920496529 CMS
Abbott Laboratories $21.4609/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920496559 CMS
Abbott Laboratories $12.8509/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920496591 CMS
Biosense Webster, Inc. $81.0409/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015033 CMS
Impulse Dynamics (USA) Inc. $82.3009/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559693 CMS
Biosense Webster, Inc. $10.1709/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015003 CMS
Merck Sharp & Dohme LLC $11.7908/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944428075 CMS
Biosense Webster, Inc. $18.9408/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015075 CMS
Abbott Laboratories $23.0608/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920520757 CMS
Abbott Laboratories $23.3008/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920520763 CMS
Impulse Dynamics (USA) Inc. $11.4508/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947561213 CMS
Biosense Webster, Inc. $10.4408/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015147 CMS
Boston Scientific Corporation $104.6108/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916809837 CMS
Biosense Webster, Inc. $12.6808/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015087 CMS
Abbott Laboratories $10.3408/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920496575 CMS
Abbott Laboratories $16.8608/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920496607 CMS
Merck Sharp & Dohme LLC $13.8508/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944429537 CMS
Impulse Dynamics (USA) Inc. $11.9108/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559679 CMS
Biosense Webster, Inc. $10.2408/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015139 CMS
Impulse Dynamics (USA) Inc. $21.8208/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559699 CMS
Abbott Laboratories $105.7408/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914224725 CMS
Biosense Webster, Inc. $18.5708/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887014987 CMS
Biosense Webster, Inc. $138.0708/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015117 CMS
Biosense Webster, Inc. $21.0008/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015111 CMS
Merck Sharp & Dohme LLC $17.4607/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944431237 CMS
Biosense Webster, Inc. $143.3907/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015105 CMS
Novartis Pharmaceuticals Corporation $2.0007/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894416651 CMS
Impulse Dynamics (USA) Inc. $1,600.0007/25/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559673 CMS
Biosense Webster, Inc. $10.2407/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015135 CMS
Biosense Webster, Inc. $31.4807/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887014913 CMS
Merck Sharp & Dohme LLC $12.7207/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944433759 CMS
Impulse Dynamics (USA) Inc. $146.5307/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559687 CMS
Abbott Laboratories $195.5107/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920496505 CMS
Biosense Webster, Inc. $11.0407/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015009 CMS
Impulse Dynamics (USA) Inc. $35.0407/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947559705 CMS
Impulse Dynamics (USA) Inc. $10.3707/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947561227 CMS
Novartis Pharmaceuticals Corporation $19.4807/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894416649 CMS
Abbott Laboratories $129.1506/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914224731 CMS
Abbott Laboratories $17.9806/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914224739 CMS
Abbott Laboratories $12.2706/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914224755 CMS
Abbott Laboratories $14.3106/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914224767 CMS
Abbott Laboratories $14.3406/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914224775 CMS
Biosense Webster, Inc. $17.8806/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015039 CMS
Abbott Laboratories $15.5506/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920496599 CMS
Biosense Webster, Inc. $15.3406/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887015045 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $750.0006/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885362691 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $8,264.26 38
PY2020 $12,280.76 40
PY2021 $7,986.69 120
PY2022 $15,408.48 175
PY2023 $8,295.47 178
PY2024 $8,331.29 206
PY2025 $16,330.43 183

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $458,862.00 14
PY2024 Principal investigator $452,007.00 14
PY2023 Principal investigator $19,865.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $14,819.00 12/12/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165982
Principal investigator 1 Janssen Research & Development, LLC $32,570.00 11/19/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166098
Principal investigator 1 Janssen Research & Development, LLC $55,687.00 11/07/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165892
Principal investigator 1 Janssen Research & Development, LLC $11,459.00 11/03/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165520
Principal investigator 1 Janssen Research & Development, LLC $19,015.00 09/19/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166021
Principal investigator 1 Janssen Research & Development, LLC $26,636.00 08/25/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165601
Principal investigator 1 Janssen Research & Development, LLC $24,376.00 07/23/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165477
Principal investigator 1 Janssen Research & Development, LLC $10,329.00 06/23/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165040
Principal investigator 1 Janssen Research & Development, LLC $20,261.00 06/20/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165069
Principal investigator 1 Janssen Research & Development, LLC $27,299.00 05/21/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165826
Principal investigator 1 Janssen Research & Development, LLC $35,867.00 04/23/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165132
Principal investigator 1 Janssen Research & Development, LLC $36,548.00 03/21/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166106
Principal investigator 1 Janssen Research & Development, LLC $67,437.00 02/19/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164933
Principal investigator 1 Janssen Research & Development, LLC $76,559.00 01/22/2025 Non-covered Recipient Entity
Arizona Crdvsclr Rsrch Fndtn
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175165443